RecruitingNot ApplicableNCT06639360

Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke

Sponsor

Xijing Hospital

Enrollment

60 participants

Start Date

Aug 2, 2025

Study Type

INTERVENTIONAL

Conditions

Ischemic Stroke, Acute Endovascular Thrombectomy

Summary

This is a multicenter, randomized, double-blind, sham-controlled trial, to determine the efficacy and safety of cTBS in treating patients with acute ischemic stroke after endovascular treatment.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Transcranial Magnetic Stimulation Active and a medical device called Transcranial Magnetic Stimulation Sham for people with endovascular thrombectomy and ischemic stroke, acute. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscranial Magnetic Stimulation Active

The patients will be treated with cTBS and usual medical treatment after endovascular treatment

DEVICETranscranial Magnetic Stimulation Sham

The patients will be treated with sham-cTBS and usual medical treatment after endovascular treatment

Locations(1)

Xijing Hospital

Xi'an, Shaanxi, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06639360

Related Trials

Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

NCT0732483722 locations

Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)

NCT0768770624 locations

Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial

NCT063526192 locations

Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA)

NCT075943141 location

Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)

NCT075943011 location